Acessibilidade / Reportar erro

Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index

Avaliação dos transtornos mentais comuns em mulheres com síndrome dos ovários policísticos e sua relação com o índice de massa corporal

Abstracts

PURPOSE: To evaluate the prevalence of common mental disorders in women diagnosed with polycystic ovary syndrome as compared with paired controls without this syndrome. METHODS: Cross-sectional study with a Control Group examining women between the ages of 18 and 30 who did not use antidepressants and who sought the Gynecology Service of the researched sites. For every woman diagnosed with the polycystic ovary syndrome, another with the same age, educational status and presence or absence of sexual partners was sought without this diagnosis. In total, 166 patients agreed to participate, consisting of 95 diagnosed with polycystic ovary syndrome and 71 in the Control Group. The diagnosis of polycystic ovary syndrome was made by the presence of two from three criteria: oligomenorrhea or amenorrhea, clinical or biochemical hyperandrogenism and polycystic ovaries on transvaginal ultrasound, following exclusion of patients with Cushing's syndrome, congenital adrenal hyperplasia, and androgen-secreting tumors. Weight and height were measured to calculate the body mass index. The Self-Reporting Questionnaire, which evaluated 20 items, was used as an indicator of common mental disorders. A χ² analysis stratified by the category of body mass index was used to compare the prevalence of common mental disorders, between the groups of women with and without the polycystic ovary syndrome. RESULTS: There were no significant differences in age, education, presence of sexual partners, ethnicity, socioeconomic status, use of psychiatric medication, and search for consultation in mental health between the studied groups. The prevalence of obese women with indications of common mental disorders was significantly higher in women with polycystic ovary syndrome than in the Control Group. In the group with healthy body mass index, the incidence of common mental disorders was statistically significant different between women with polycystic ovary syndrome and normal controls (p=0.008). CONCLUSIONS: Women with diagnosis of this disease have an almost three-fold increased likelihood of common mental disorders as compared with those without polycystic ovary syndrome. Although obesity is often observed in polycystic ovary syndrome, even women with a healthy body mass index have an increased risk of psychiatric comorbidity.

Polycystic ovary syndrome; Mental health; Obesity; Body mass index; Women's health


OBJETIVOS: Avaliar a prevalência dos transtornos mentais comuns em mulheres diagnosticadas com síndrome dos ovários policísticos e compará-las com controles pareadas sem a doença. MÉTODOS: Estudo transversal com Grupo Controle. Participaram mulheres entre 18 e 30 anos que não faziam uso de antidepressivos e procuraram o Serviço de Ginecologia dos locais de pesquisa. Para cada mulher diagnosticada com a síndrome dos ovários policísticos, buscou-se outra sem este diagnóstico com mesma idade, condição de escolaridade e presença ou ausência de parceiro sexual fixo. No total, 166 pacientes aceitaram participar, sendo 95 diagnosticadas com a síndrome e 71 no Grupo Controle. Para o diagnóstico da síndrome dos ovários policísticos, foi necessário existir dois dos três critérios: oligomenorreia ou amenorreia; hiperandrogenismo clínico ou bioquímico; ovários policísticos na ecografia transvaginal e excluir presença da síndrome de Cushing, hiperplasia adrenal congênita e tumores secretores de androgênio. Peso e altura foram aferidos para calcular o índice de massa corporal, enquanto o indicativo de transtorno mental comum foi avaliado pelo Self-Reporting Questionnaire com 20 itens. Foi realizado o teste do χ²em análise estratificada por categoria de índice de massa corporal para comparar as prevalências dos transtornos mentais comuns no grupo de mulheres com e sem a síndrome. RESULTADOS: Não houve diferenças significativas quanto à idade, escolaridade, presença de parceiro sexual fixo, cor da pele, nível socioeconômico, uso de medicação psiquiátrica e procura por consulta em saúde mental entre os grupos estudados. A prevalência de mulheres obesas e com indicações de transtornos mentais comuns foi significativamente maior no grupo de mulheres com síndrome dos ovários policísticos do que no Grupo Controle. No grupo com índice de massa corporal saudável, a diferença de proporções referentes ao indicativo de transtorno mental comum entre mulheres com e sem a síndrome foi estatisticamente significativa (p=0,008). CONCLUSÕES: As mulheres com o diagnóstico desta síndrome apresentam proporção quase três vezes maior de transtornos mentais comuns quando comparadas com àquelas sem a doença. Mesmo as mulheres com a síndrome e o índice de massa corporal saudáveis apresentam maior risco de comorbidade psiquiátrica.

Síndrome do ovário policístico; Saúde mental; Obesidade; Índice de massa corporal; Saúde da mulher


ORIGINAL ARTICLE

Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index

Avaliação dos transtornos mentais comuns em mulheres com síndrome dos ovários policísticos e sua relação com o índice de massa corporal

Cristine Eliane Gomes RodriguesI; Luana de Lima FerreiraII; Karen JansenI; Mariane Ricardo Acosta LopezI; Cláudio Raul Drews JúniorI; Luciano Dias de Mattos SouzaI

IPrograma de Pós-Graduação em Saúde e Comportamento, Universidade Católica de Pelotas - UCPel - Pelotas (RS), Brazil

IICurso de Graduação em Psicologia, Universidade Católica de Pelotas - UCPel - Pelotas (RS), Brazil

Correspondence Correspondence Cristine Eliane Gomes Rodrigues Rua Gonçalves Chaves 373 - Campus 1 - Sala 411 C - Prédio C CEP: 96015-560 - Centro Pelotas (RS), Brasil.

ABSTRACT

PURPOSE: To evaluate the prevalence of common mental disorders in women diagnosed with polycystic ovary syndrome as compared with paired controls without this syndrome.

METHODS: Cross-sectional study with a Control Group examining women between the ages of 18 and 30 who did not use antidepressants and who sought the Gynecology Service of the researched sites. For every woman diagnosed with the polycystic ovary syndrome, another with the same age, educational status and presence or absence of sexual partners was sought without this diagnosis. In total, 166 patients agreed to participate, consisting of 95 diagnosed with polycystic ovary syndrome and 71 in the Control Group. The diagnosis of polycystic ovary syndrome was made by the presence of two from three criteria: oligomenorrhea or amenorrhea, clinical or biochemical hyperandrogenism and polycystic ovaries on transvaginal ultrasound, following exclusion of patients with Cushing's syndrome, congenital adrenal hyperplasia, and androgen-secreting tumors. Weight and height were measured to calculate the body mass index. The Self-Reporting Questionnaire, which evaluated 20 items, was used as an indicator of common mental disorders. A χ2 analysis stratified by the category of body mass index was used to compare the prevalence of common mental disorders, between the groups of women with and without the polycystic ovary syndrome.

RESULTS: There were no significant differences in age, education, presence of sexual partners, ethnicity, socioeconomic status, use of psychiatric medication, and search for consultation in mental health between the studied groups. The prevalence of obese women with indications of common mental disorders was significantly higher in women with polycystic ovary syndrome than in the Control Group. In the group with healthy body mass index, the incidence of common mental disorders was statistically significant different between women with polycystic ovary syndrome and normal controls (p=0.008).

CONCLUSIONS: Women with diagnosis of this disease have an almost three-fold increased likelihood of common mental disorders as compared with those without polycystic ovary syndrome. Although obesity is often observed in polycystic ovary syndrome, even women with a healthy body mass index have an increased risk of psychiatric comorbidity.

Keywords: Polycystic ovary syndrome, Mental health, Obesity, Body mass index, Women's health.

RESUMO

OBJETIVOS: Avaliar a prevalência dos transtornos mentais comuns em mulheres diagnosticadas com síndrome dos ovários policísticos e compará-las com controles pareadas sem a doença.

MÉTODOS: Estudo transversal com Grupo Controle. Participaram mulheres entre 18 e 30 anos que não faziam uso de antidepressivos e procuraram o Serviço de Ginecologia dos locais de pesquisa. Para cada mulher diagnosticada com a síndrome dos ovários policísticos, buscou-se outra sem este diagnóstico com mesma idade, condição de escolaridade e presença ou ausência de parceiro sexual fixo. No total, 166 pacientes aceitaram participar, sendo 95 diagnosticadas com a síndrome e 71 no Grupo Controle. Para o diagnóstico da síndrome dos ovários policísticos, foi necessário existir dois dos três critérios: oligomenorreia ou amenorreia; hiperandrogenismo clínico ou bioquímico; ovários policísticos na ecografia transvaginal e excluir presença da síndrome de Cushing, hiperplasia adrenal congênita e tumores secretores de androgênio. Peso e altura foram aferidos para calcular o índice de massa corporal, enquanto o indicativo de transtorno mental comum foi avaliado pelo Self-Reporting Questionnaire com 20 itens. Foi realizado o teste do χ2 em análise estratificada por categoria de índice de massa corporal para comparar as prevalências dos transtornos mentais comuns no grupo de mulheres com e sem a síndrome.

RESULTADOS: Não houve diferenças significativas quanto à idade, escolaridade, presença de parceiro sexual fixo, cor da pele, nível socioeconômico, uso de medicação psiquiátrica e procura por consulta em saúde mental entre os grupos estudados. A prevalência de mulheres obesas e com indicações de transtornos mentais comuns foi significativamente maior no grupo de mulheres com síndrome dos ovários policísticos do que no Grupo Controle. No grupo com índice de massa corporal saudável, a diferença de proporções referentes ao indicativo de transtorno mental comum entre mulheres com e sem a síndrome foi estatisticamente significativa (p=0,008).

CONCLUSÕES: As mulheres com o diagnóstico desta síndrome apresentam proporção quase três vezes maior de transtornos mentais comuns quando comparadas com àquelas sem a doença. Mesmo as mulheres com a síndrome e o índice de massa corporal saudáveis apresentam maior risco de comorbidade psiquiátrica.

Palavras-chave: Síndrome do ovário policístico, Saúde mental, Obesidade, Índice de massa corporal, Saúde da mulher.

Introduction

The polycystic ovary syndrome (PCOS) is an endocrine-gynecological disorder that affects between 5 and 10% of reproductive-age women1-7, and it is characterized by hyperandrogenism, insulin resistance, and chronic anovulation. Clinical manifestations include hirsutism, acne, alopecia, obesity, menstrual irregularity and infertility, but all of these symptoms do not necessarily occur in aggregation1,8. They exhibit heterogeneous expression, with marked differences in prevalence and intensity between different groups of women with PCOS2. PCOS encompasses not only an endocrine condition, but also a reproductive and psychological syndrome for women with PCOS have their self-image and physical appearance changed by obesity, hirsutism and acne in addition to experiencing infertility. These symptoms occur with lifestyle changes that might generate sexual dissatisfaction and depression9,10.

Some studies report an association between polycystic ovaries and high level of depression and anxiety, affecting quality of life and leading to a reduction of sleep and an increased incidence of phobias and panic5. The relationship between affective disorders and the endocrine system has been extensively studied, and interest in this field has been growing in recent years. PCOS is a disorder closely related to women's physical appearances, causing a change in their body image that may lead to depression8.

National literature about this subject is still scarce. A study conducted in Rio de Janeiro with 72 patients showed that 57% had at least one psychiatric diagnosis11. Among the most frequent diagnoses were major depressive and bipolar disorders. Comorbidity of PCOS with a psychiatric disorder may increase functional damage. Similarly, some drug treatments for mood disorders have been reported to be associated with such syndrome's development11.

The objective of this study was to evaluate the prevalence of common mental disorders in women diagnosed with PCOS as compared with paired controls without it.

Methods

This is a cross-sectional study including a Control Group, which was carried out from February 2011 to December 2012. Women between 18 and 30 years of age who sought the services of gynecology and did not use antidepressants were invited to participate. For every woman diagnosed with PCOS, another one with the same age, educational status, and presence or absence of sexual partners was sought without this diagnosis. In total, 166 patients agreed to participate, consisting of 95 diagnosed with PCOS and 71 in the Control Group. The study was conducted at four clinics that had specialized gynecology departments, which were: Fundação de Apoio Universitário, Posto de Saúde Virgilio Costa, Hospital Clinicamp, and Clínica de Ultrassonografia Centrus. This study was approved by the Research Ethics Committee of Universidade Católica de Pelotas and Fundação de Apoio Universitário (protocol number 2011/03). All interviewees were informed by the researchers about the study aims and confirmed the protection of their identities by reading and signing the statement of consent.

Instrument for data collection

The present scientific investigation used the criteria for PCOS diagnosis based on a consensus carried out in 200312, which dictates the need for the presence of two of the three following criteria for such diagnosis: oligomenorrhea or amenorrhea, hyperandrogenism and polycystic ovarian morphology by ultrasound3,4,13. Based on this consensus, several authors have studied ovarian morphology and defined how to evaluate ovaries by ultrasound4,14.

The participants were invited to answer a questionnaire that evaluated sociodemographic data and indications of common mental disorders. Additionally, the participants were assessed for height and weight.

The socioeconomic assessment of the participants was accomplished with the rating scale from the Brazilian Association of Research Companies, based on the accumulation of material goods and on the education level of the household head. This tool ranks the socioeconomic situation as 'A, B, C, D and E', with A being the highest socioeconomic status and E, the lowest15.

Calculation of the body mass index (BMI) was performed by dividing weight in kilograms by the square of height in meters. Scores between 18.6 and 24.9 were categorized as healthy, those between 25 and 29.9 as overweight and above 30 as obese16.

The indication of common mental disorders was assessed by the Self-Reporting Questionnaire 20 items (SRQ scale-20), which measures symptoms of anxiety, mood and somatoform disorders. This evaluation is recommended by the World Health Organization (WHO) and it was validated for the Brazilian population by Mari and Williams17. In this study, a score above seven points was considered an indication of common mental disorders.

Sample calculation and data analysis

The present research is part of a larger project, therefore the samples were calculated on the basis of that aim and data collection is still under progress. However, considering the number of participants in each study group and the outcome proportions of common mental disorders, enrolling 166 women ensures reliability of 95% and statistical power of 92% to differentiate the prevalence of indications of common mental disorders between women with and without a diagnosis of PCOS. The calculation of reliability and statistical powers was performed using Epi-Info, version 6.04.

Data were coded with standardized characters and double-entered in Epi-Info 6.4 for further verification and correction of inconsistencies in data entry. For data analysis, the χ2 test was used to verify differences in proportions, and the t-test was used to observe differences in means. Finally, we performed a χ2 analysis following categorization by BMI to check differences in indication proportions of common mental disorders, among groups of women with and without PCOS.

Results

The current study included 166 women, of which 95 were diagnosed with PCOS while 71 were in the matched Control Group.

The pairing proposed for the formation of study groups was effective because there were no statistically significant differences between them in age, educational level, and presence of a steady partner. The average age of women with PCOS was 24.36 (3.56) years-old, while the Control Group participants had a mean age of 24.38 (3.75) years-old. In the group of participants with PCOS, the percentage of women with sexual partners was 89.1%, while 91.5% of the Control Group also reported having sexual partners. Regarding education, in the group of women diagnosed with PCOS, 48.4% completed high school and 37.9% held a college degree, while in the Control Group, these proportions were 50.7 and 39.4%, respectively.

Table 1 summarizes the characterization and differentiation of both groups. The proportion of obese women with indicators of common mental disorders was significantly higher in women with PCOS than in the Control Group.

After the analysis had been stratified by the BMI (Table 2), the difference in the percentage of women with a healthy BMI and indications of common mental disorders was statistically significant among those with and without PCOS (p=0.008).

Discussion

In the gynecological consultation room, routine questioning of patients about emotional symptoms is uncommon. However, the presence of mental health complaints can also emerge at this moment18, highlighting the need for guidance and monitoring. The present study emphasizes that women with PCOS have an almost three times higher likelihood of common mental disorders as compared with those without it. This finding is corroborated by other studies that point to the high demand for mental healthcare in this population5,11.

However, part of the scientific literature suggests the negative impact of obesity on female self-esteem as a possible explanation for such high prevalence of psychiatric disorders6. In contrast, the prospect exists that all women with PCOS have concerns about their weight, and therefore, mental disorders occur independently of BMI, thus it is not in fact a differential characteristic19,20. The data presented here indicate that even healthy-weight women with PCOS have an increased risk of psychiatric comorbidity. These data are in agreement with a recent meta-analysis, which shows a four-fold increased risk for depression in women with PCOS independent of the BMI21.

Limitations in this study included small number of obese women, especially those without a diagnosis of PCOS. It is likely that the same result found among healthy women is present in the other groups. The study design required the reverse causality bias, therefore it is not possible to distinguish which condition was first manifested, PCOS or common mental disorders. However, we propose that PCOS can leave women more emotionally vulnerable, due not only to the consequences of being overweight or obese, but also to other features of the syndrome that potentially have similar implications, such as hirsutism10, acne22, and infertility23. Still, hormonal changes as indicated by the clinical features of PCOS may also contribute significantly to the appearance of mental disorders in affected women24,25. Thus, it is important that future studies seek to assess the relationship between mental disorders, especially mood ones, and PCOS through hormonal and genetic evaluations.

In clinical practice, there is the need for awareness of health professionals, especially the gynecologist, in order to inquire about the mental health of his/her patient and refer him/her to a mental health professional, who is able to follow-up and continue the treatment whenever is necessary. A multidisciplinary team composed of a gynecologist, psychologist and endocrinologist would be ideal so that together the group can care for the patient to assess his/her interactions, medication, and continued treatment.

Conflict of interest: none.

Received 03/08/2012

Accepted with modifications 17/09/2012

Study carried out at Universidade Católica de Pelotas

  • 1. Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998;83(6):1976-87.
  • 2. Moreira S, Soares E, Tomaz G, Maranhão T, Azevedo G. Síndrome dos ovários policísticos: enfoque psicossocial. Acta Med Port. 2010;23(2):237-42.
  • 3. Merino P, Schulin-Zeuthen C, Codner E. Diagnóstico del Síndrome de Ovario Poliquístico: nuevos fenotipos, nuevas incógnitas. Rev Med Chil. 2009;137(8):1071-80.
  • 4. Lakhani K, Seifalian AM, Atiomo WU, Hardiman P. Polycystic ovaries. Br J Radiol. 2002;75(889):9-16.
  • 5. Jedel E, Waern M, Gustafson D, Landén M, Eriksson E, Holm G, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum Reprod. 2010;25(2):450-6.
  • 6. Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol. 2006;11(4):613-25.
  • 7. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril. 2009;91(1):207-12.
  • 8. Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord. 2003;74(3):299-304.
  • 9. Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril. 2010;93(7):2421-3.
  • 10. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol. 2005;153(6): 853-60.
  • 11. Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, Bruno RV, et al. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry. 2010;51(6): 599-602.
  • 12. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7.
  • 13. Broekmans FJ, Fauser BC. Diagnostic criteria for polycystic ovarian syndrome. Endocrine. 2006;30(1):3-11.
  • 14. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9(6):505-14
  • 15
    Associação Brasileira de Empresas de Pesquisa. Critério de Classificação Econômica Brasil: CCEB 2009 [Internet]. São Paulo: ABEP; 2010 [citado 2009 Set 1]. Disponível em: <http://www.abep.org/novo/Content.aspx?ContentID=302>
    » link
  • 16
    World Health Organization. Obesity preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO; 1997.
  • 17. Mari JJ, Williams P. A validity study of a psychiatric screening questionnaire (SRQ-20) in primary care in the city of São Paulo. Br J Psychiatry. 1986;148(1):23-6.
  • 18. Cipkala-Gaffin J, Talbott EO, Song MK, Bromberger J, Wilson J. Associations between psychologic symptoms and life satisfaction in women with polycystic ovary syndrome. J Womens Health (Larchmt). 2012;21(2):179-87.
  • 19. Jones GL, Hall JM, Balen AH, Ledger WL. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2008;14(1):15-25.
  • 20. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007;87(6):1369-76.
  • 21. Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2011;117(1):145-52.
  • 22. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279-86.
  • 23. Tan S, Hahn S, Benson S, Janssen OE, Dietz T, Kimmig R, et al. Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod. 2008;23(9):2064-71.
  • 24. Livadas S, Chaskou S, Kandaraki AA, Skourletos G, Economou F, Christou M, et al. Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf). 2011;75(5):698-703.
  • 25. Jedel E, Gustafson D, Waern M, Sverrisdottir YB, Landén M, Janson PO, et al. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome. Psychoneuroendocrinology. 2011;36(10):1470-9.
  • Correspondence
    Cristine Eliane Gomes Rodrigues
    Rua Gonçalves Chaves 373 - Campus 1 - Sala 411 C - Prédio C
    CEP: 96015-560 - Centro
    Pelotas (RS), Brasil.
  • Publication Dates

    • Publication in this collection
      20 Dec 2012
    • Date of issue
      Oct 2012

    History

    • Received
      03 Aug 2012
    • Accepted
      17 Sept 2012
    Federação Brasileira das Sociedades de Ginecologia e Obstetrícia Av. Brigadeiro Luís Antônio, 3421, sala 903 - Jardim Paulista, 01401-001 São Paulo SP - Brasil, Tel. (55 11) 5573-4919 - Rio de Janeiro - RJ - Brazil
    E-mail: editorial.office@febrasgo.org.br